Article Versions Notes

Mak K-K, Zhang S, Chellian J, Mohd Z, Epemolu O, Dinkova-Kostova AT, Balijepalli MK, Pichika MR. Swietenine Alleviates Nonalcoholic Fatty Liver Disease in Diabetic Mice via Lipogenesis Inhibition and Antioxidant Mechanisms. Antioxidants. 2023; 12(3):595. https://doi.org/10.3390/antiox12030595

Mak, Kit-Kay, Shiming Zhang, Jestin Chellian, Zulkefeli Mohd, Ola Epemolu, Albena T. Dinkova-Kostova, Madhu Katyayani Balijepalli, and Mallikarjuna Rao Pichika. 2023. "Swietenine Alleviates Nonalcoholic Fatty Liver Disease in Diabetic Mice via Lipogenesis Inhibition and Antioxidant Mechanisms" Antioxidants 12, no. 3: 595. https://doi.org/10.3390/antiox12030595

Mak, K.-K., Zhang, S., Chellian, J., Mohd, Z., Epemolu, O., Dinkova-Kostova, A. T., Balijepalli, M. K., & Pichika, M. R. (2023). Swietenine Alleviates Nonalcoholic Fatty Liver Disease in Diabetic Mice via Lipogenesis Inhibition and Antioxidant Mechanisms. Antioxidants, 12(3), 595. https://doi.org/10.3390/antiox12030595